IL1B and osteoarthritis: Moreover, the inhibition of the NF-κB signaling pathway by IL-1β and TNF-α decreases the inflammation of joints and tissue degradation and prevents the effects of iNOS and MMP, which cause inflammation and articular cartilage breakdown in osteoarthritis [73].